Bone Morphogenetic Proteins: Inhibitors of Myelination in Development and Disease

Vitamins and Hormones

Volumn 99, Issue , 2015, Pages 195-222

  Grinspan, Judith B ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Astrocytes; Bone morphogenetic protein; Multiple Sclerosis; Myelin; Noggin; Oligodendrocyte progenitor cells; Oligodendrocytes; Perinatal white matter injury; Spinal cord injury

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; CARRIER PROTEIN; NOGGIN PROTEIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CEREBROVASCULAR ACCIDENT; CYTOLOGY; GENETICS; HUMAN; LEUKOENCEPHALOPATHY; METABOLISM; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; PATHOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; HUMANS; LEUKOENCEPHALOPATHIES; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; STROKE;

EID: 84932166028     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.vh.2015.05.005     Document Type: Chapter

References (110)

1. Aguirre A., Dupree J.L., Mangin J.M., Gallo V. A functional role for EGFR signaling in myelination and remyelination. Nature Neuroscience 2007, 10(8):990-1002.
2. Ahn K., Mishina Y., Hanks M.C., Behringer R.R., Crenshaw E.B. BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development 2001, 128(22):4449-4461.
3. Alberdi E., Sanchez-Gomez M.V., Torre I., Domercq M., Perez-Samartin A., Perez-Cerda F., et al. Activation of kainate receptors sensitizes oligodendrocytes to complement attack. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2006, 26(12):3220-3228.
4. Alberta J.A., Park S.K., Mora J., Yuk D.I., Pawlitzky I., Iannarelli P., et al. Sonic hedgehog is required during an early phase of oligodendrocyte development in mammalian brain. Molecular and Cellular Neurosciences 2001, 18(4):434-441.
5. Ara J., See J., Mamontov P., Hahn A., Bannerman P., Pleasure D., et al. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. Journal of Neuroscience Research 2008, 86(1):125-135.
6. Back S.A., Han B.H., Luo N.L., Chricton C.A., Xanthoudakis S., Tam J., et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. The Journal of Neuroscience 2002, 22(2):455-463.
7. Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. The Journal of Neuroscience 2001, 21(4):1302-1312.
8. Back S.A., Tuohy T.M., Chen H., Wallingford N., Craig A., Struve J., et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nature Medicine 2005, 11(9):966-972.
9. Bannerman P., Hahn A., Soulika A., Gallo V., Pleasure D. Astrogliosis in EAE spinal cord: Derivation from radial glia, and relationships to oligodendroglia. Glia 2007, 55(1):57-64.
10. Bansal R. Fibroblast growth factors and their receptors in oligodendrocyte development: Implications for demyelination and remyelination. Developmental Neuroscience 2002, 24(1):35-46.
11. Bansal R., Stefansson K., Pfeiffer S.E. Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. Journal of Neurochemistry 1992, 58:2221-2229.
12. Barres B.A., Lazar M.A., Raff M.C. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 1994, 120(5):1097-1108.
13. Bilican B., Fiore-Heriche C., Compston A., Allen N.D., Chandran S. Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS One 2008, 3(8):e2863.
14. Casaccia-Bonnefil P., Hardy R.J., Teng K.K., Levine J.M., Koff A., Chao M.V. Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 1999, 126(18):4027-4037.
15. Cate H.S., Sabo J.K., Merlo D., Kemper D., Aumann T.D., Robinson J., et al. Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination. Journal of Neurochemistry 2010, 115(1):11-22.
16. Chandran S., Kato H., Gerreli D., Compston A., Svendsen C.N., Allen N.D. FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway. Development 2003, 130(26):6599-6609.
17. Chen J., Leong S.Y., Schachner M. Differential expression of cell fate determinants in neurons and glial cells of adult mouse spinal cord after compression injury. The European Journal of Neuroscience 2005, 22(8):1895-1906.
18. Cheng X., Wang Y., He Q., Qiu M., Whittemore S.R., Cao Q. Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells 2007, 25(12):3204-3214.
19. Colak D., Mori T., Brill M.S., Pfeifer A., Falk S., Deng C., et al. Adult neurogenesis requires Smad4-mediated bone morphogenic protein signaling in stem cells. The Journal of Neuroscience 2008, 28(2):434-446.
20. Connor J.R., Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 1996, 17(2):83-93.
21. Deininger M., Meyermann R., Schluesener H. Detection of two transforming-growth-factor-beta-related morphogens, bone morphogenetic proteins-4 and -5, in RNA of multiple sclerosis and Creutzfeld-Jakob disease lesion. Acta Neuropathologica 1995, 90:76-79.
22. Dizon M.L., Maa T., Kessler J.A. The bone morphogenetic protein antagonist noggin protects white matter after perinatal hypoxia-ischemia. Neurobiology of Disease 2011, 42(3):318-326.
23. Dummula K., Vinukonda G., Chu P., Xing Y., Hu F., Mailk S., et al. Bone morphogenetic protein inhibition promotes neurological recovery after intraventricular hemorrhage. The Journal of Neuroscience 2011, 31(34):12068-12082.
24. Emery B. Regulation of oligodendrocyte differentiation and myelination. Science 2010, 330(6005):779-782.
25. Enzmann G.U., Benton R.L., Woock J.P., Howard R.M., Tsoulfas P., Whittemore S.R. Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal cord. Experimental Neurology 2005, 195(2):293-304.
26. Fancy S.P., Barazini S.E., Zhao C., Yuk D.I., Irvine K.A., Kaing S., et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes and Development 2009, 23:1571-1585.
27. Feigenson K., Reid M., See J., Crenshaw E.B., Grinspan J.B. Canonical Wnt signaling requires the BMP pathway to inhibit oligodendrocyte maturation. ASN Neuro 2011, 3(3):e00061. 10.1042/AN20110004.
28. Feigenson K., Reid M., See J., Crenshaw E.B., Grinspan J.B. Wnt signaling is sufficient to perturb oligodendrocyte maturation. Molecular and Cellular Neuroscience 2009, 42:255-265.
29. Fuller M.L., Dechant A.K., Rothstein B., Caprariello A., Wang R., Hall A.K., et al. Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions. Annals of Neurology 2007, 62(3):288-300.
30. Goldschmidt T., Antel J., Konig F.B., Bruck W., Kuhlmann T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009, 72(22):1914-1921.
31. Gomes W.A., Mehler M.F., Kessler J.A. Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Developmental Biology 2003, 255(1):164-177.
32. Grinspan J.B., Edell E., Carpio D.F., Beesley J.S., Lavy L., Pleasure D., et al. Stage-specific effects of bone morphogenetic proteins on the oligodendrocyte lineage. Journal of Neurobiology 2000, 43(1):1-17.
33. Grinspan J., Wrabetz L., Kamholz J. Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matter. Journal of Neurocytology 1993, 22:322-333.
34. Gross R.E., Mehler M.F., Mabie P.C., Zang Z., Santschi L., Kessler J.A. Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 1996, 17(4):595-606.
35. Haynes R.L., Folkerth R.D., Keefe R.J., Sung I., Swzeda L.I., Rosenberg P.A., et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. Journal of Neuropathology and Experimental Neurology 2003, 62(5):441-450.
36. Hertz L. Bioenergetics of cerebral ischemia: A cellular perspective. Neuropharmacology 2008, 55(3):289-309. (Review).
37. Ishibashi T., Dakin K.A., Stevens B., Lee P.R., Kozlov S.V., Stewart C.L., et al. Astrocytes promote myelination in response to electrical impulses. Neuron 2006, 49(6):823-832.
38. Izrael M., Zhang P., Kaufman R., Shinder V., Ella R., Amit M., et al. Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Molecular and Cellular Neurosciences 2007, 34:310-323.
39. Jablonska B., Aguirre A., Raymond M., Szabo G., Kitabatake Y., Sailor K.A., et al. Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination. Nature Neuroscience 2010, 13(5):541-550.
40. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., et al. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nature Medicine 2002, 8(10):1115-1121. (see comment).
41. Jurynczyk M., Jurewicz A., Bielecki B., Raine C.S., Selmaj K. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. Journal of Neuroimmunology 2005, 170(1-2):3-10.
42. Kasai M., Satoh K., Akiyama T. Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs. Genes to Cells 2005, 10:777-783.
43. Kessaris N., Fogarty M., Iannarelli P., Grist M., Wegner M., Richardson W.D. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nature Neuroscience 2006, 9:173-179.
44. Khwaja O., Volpe J.J. Pathogenesis of cerebral white matter injury of prematurity. Archives of Disease in Childhood. Fetal and Neonatal Edition 2008, 93(2):F153-F161.
45. Kinney H.C. The near-term (late preterm) human brain and risk for periventricular leukomalacia: A review. Seminars in Perinatology 2006, 30(2):81-88.
46. Kondo T., Raff M. The Id4 HLH protein and the timing of oligodendrocyte differentiation. The EMBO Journal 2000, 19:1998-2007.
47. Kondo T., Raff M.C. A role for Noggin in the development of oligodendrocyte precursor cells. Developmental Biology 2004, 267(1):242-251.
48. Kretzschmar M., Doody J., Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 1997, 389(6651):618-622.
49. Lasiene J., Shupe L., Perlmutter S., Horner P. No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2008, 28(15):3887-3896.
50. Liem K.F., Jessell T.M., Briscoe J. Regulation of the neural patterning activity of sonic hedgehog by secreted BMP inhibitors expressed by notochord and somites. Development 2000, 127(22):4855-4866.
51. Liem K.F., Tremml G., Roelink H., Jessell T.M. Dorsal differentiation of neural plate cells induced by BMP-mediated signals from epidermal ectoderm. Cell 1995, 82(6):969-979.
52. Lu Q.R., Cai L., Rowitch D., Cepko C.L., Stiles C.D. Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex. Nature Neuroscience 2001, 4(10):973-974.
53. Lu Q.R., Sun T., Zhu Z., Ma N., Garcia M., Stiles C.D., et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002, 109(1):75-86.
54. Lu Q.R., Yuk D.-I., Alberta J.A., Zhu Z., Pawlitzky I., Chan J., et al. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mamalian central nervous system. Neuron 2000, 25:317-329.
55. Mabie P.C., Mehler M.F., Marmur R., Papavasiliou A., Song Q., Kessler J.A. Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells. The Journal of Neuroscience 1997, 17(11):4112-4120.
56. Marin-Husstege M., Muggironi M., Liu A., Casaccia-Bonnefil P. Histone deacetylase activity is necessary for oligodendrocyte lineage progression. The Journal of Neuroscience 2002, 22(23):10333-10345.
57. Martinez G., Carnazza M., Dii Giacomo C., Sorrenti V., Vanella A. Expression of bone morphogenetic protein 6 and transforming growth factor b1 in the rat brain after a mild and reversible ischemic damage. Brain Research 2001, 894:1-11.
58. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathology 2001, 11(1):107-116.
59. McKinnon R.D., Smith C., Behar T., Smith T., Dubois-Dalcq M. Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells. Glia 1993, 7:245-254.
60. McMorris F.A., Dubois-Dalcq M. Insulin-like growth factor 1 promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. Journal of Neuroscience Research 1988, 21:199-209.
61. Mekki-Dauriac S., Agius E., Kan P., Cochard P. Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord. Development 2002, 129(22):5117-5130.
62. Miller R.H., Dinsio K., Wang R., Geertman R., Maier C.E., Hall A.K. Patterning of spinal cord oligodendrocyte development by dorsally derived BMP4. Journal of Neuroscience Research 2004, 76(1):9-19.
63. Milner R., Anderson H.J., Rippon R.F., McKay J.S., Franklin R.J., Marchionni M.A., et al. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration. Glia 1997, 19(1):85-90.
64. Nait-Oumesmar B., Picard-Riera N., Kerninon C., Decker L., Seilhean D., Hoglinger G.U., et al. Activation of the subventricular zone in multiple sclerosis: Evidence for early glial progenitors. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(11):4694-4699.
65. Nave K.A. Myelination and support of axonal integrity by glia. Nature 2010, 468(7321):244-252.
66. Nicolay D.J., Doucette J.R., Nazarali A.J. Transcriptional control of oligodendrogenesis. Glia 2007, 55(13):1287-1299.
67. Nishiyama A., Lin X.-H., Giese N., Heldin C.-H., Stallcup W.B. Interaction between NG2 proteonglycan and PDGF α-receptor on O2A progenitor cells is required for optimal response to PDGF. Journal of Neuroscience Research 1996, 43:315-330.
68. Ohkawara B., Iemura S., ten Dijke P., Ueno N. Action range of BMP is defined by its N-terminal basic amino acid core. Current Biology 2002, 12(3):205-209.
69. Orentas D.M., Hayes J.E., Dyer K.L., Miller R.H. Sonic hedgehog signaling is required during the appearance of spinal cord oligodendrocyte precursors. Development 1999, 126:2419-2429.
70. Park Y.M., Lee W.T., Bokara K.K., Seo S.K., Park S.H., Kim J.H., et al. The multifaceted of effects of agmatine on functional recovery after spinal cord injury through modulations of BMP-2/4/7 expressions in neurons and glial cells. PLoS One 2013, 8:e53911.
71. Peterside I.E., Selak M.A., Simmons R.A. Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats. American Journal of Physiology. Endocrinology and Metabolism 2003, 285(6):E1258-E1266.
72. Piddlesden S., Lassman H., Laffafian I., Morgan B.P., Linington C. Antibody-mediated demyelination in experimental allergic encephalomyelitis is independent of complement membrane attack complex formation. Clinical and Experimental Immunology 1991, 83:245-250.
73. Pringle N.P., Yu W.P., Guthrie S., Roelink H., Lumsden A., Peterson A.C., et al. Determination of neuroepithelial cell fate: Induction of the oligodendrocyte lineage by ventral midline cells and sonic hedgehog. Developmental Biology 1996, 177(1):30-42.
74. Raff M.C., Miller R.H., Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on the culture medium. Nature 1983, 303:390-396.
75. Raff M.C., Mirsky R., Fields K.L., Lisak R.P., Dorfman S.H., Silberberg D.H., et al. Galactocerebroside: A cell specific surface antigen marker for oligodendrocytes in culture. Nature 1978, 274:813-816.
76. Raine C.S. Multiple sclerosis: Immunopathologic mechanisms in the progression and resolution of inflammatory demyelination. Research Publications - Association for Research in Nervous and Mental Disease 1990, 68:37-54.
77. Raine C.S., Bonetti B., Cannella B. Multiple sclerosis: Expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Revue Neurologique 1998, 154(8-9):577-585.
78. Ranscht B., Clapschaw P.A., Price J., Noble M., Seifert W. Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proceedings of the National Academy of Sciences of the United States of America 1982, 79:2709-2713.
79. Reid M.V., Murray K.A., Marsh E.D., Golden J.A., Simmons R.A., Grinspan J.B. Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. Journal of Neuropathology and Experimental Neurology 2012, 71(7):640-653.
80. Sabo J.K., Aumann T.D., Merlo D., Kilpatrick T.J., Cate H.S. Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions. The Journal of Neuroscience 2011, 31(12):4504-4510.
81. Samanta J., Alden T., Gobeske K., Kan L., Kessler J.A. Noggin protects against ischemic brain injury in rodents. Stroke 2010, 41:357-362.
82. Samanta J., Burke G.M., McGuire T., Pisarek A.J., Mukhopadhyay A., Mishina Y., et al. BMPR1a signaling determines numbers of oligodendrocytes and calbindin-expressing interneurons in the cortex. The Journal of Neuroscience 2007, 27(28):7397-7407.
83. Samanta J., Kessler J.A. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 2004, 131:4131-4142.
84. Sander B., Rivera F.J., Caioni M., Nicholson L., Eckstein V., Bogdahn U., et al. Bone morphogenetic proteins prevent bone marrow stromal cell-mediated oligodendroglial differentiation of transplanted adult neural progenitor cells in the injured spinal cord. Stem Cell Research 2013, 11:758-771.
85. Scherer S., Braun P., Grinspan J., Collarini E., Wang D.-Y., Kamholz J. Differential regulation of the 2'3'-cyclic nucleotide 3'-phosphodiesterase gene in oligodendrocyte development. Neuron 1994, 12:1-20.
86. See J., Mamontov P., Ahn K., Wine-Lee L., Crenshaw E.B., Grinspan J.B. BMP signaling mutant mice exhibit glial cell maturation defects. Molecular and Cellular Neurosciences 2007, 35(1):171-182.
87. See J., Zhang X., Eraydin N., Mun S.B., Mamontov P., Golden J.A., et al. Oligodendrocyte maturation is inhibited by bone morphogenetic protein. Molecular and Cellular Neurosciences 2004, 26(4):481-492.
88. Segovia K.N., McClure M., Moravec M., Luo N.L., Wan Y., Gong X., et al. Arrested oligodendrocyte lineage maturation in chornic perinatal whilte matter injury. Annals of Neurology 2008, 63:520-530.
89. Selak M.A., Storey B.T., Peterside I., Simmons R.A. Impaired oxidative phosphorylation in skeletal muscle of intrauterine growth-retarded rats. American Journal of Physiology. Endocrinology and Metabolism 2003, 285(1):E130-E137.
90. Selmaj K., Raine C.S., Cannella B., Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. The Journal of Clinical Investigation 1991, 87(3):949-954.
91. Setoguchi T., Nakashima K., Takizawa T., Yanagisawa M., Ochiai W., Okabe M., et al. Treatment of spinal cord injury by transplantation of fetal neural precursors cells engineered to express BMP inhibitor. Experimental Neurology 2004, 189:33-44.
92. Setoguchi T., Yone K., Matsuoka E., Takenouchi H., Nakashima K., Sakou T., et al. Traumatic injury-induced BMP 7 expression in the adult rat spinal cord. Brain Research 2001, 921:219-225.
93. Soshnikova N., Zechner D., Huelsken J., Mishina Y., Behringer R.R., Taketo M.M., et al. Genetic interaction between Wnt/beta-catenin and BMP receptor signaling during formation of the AER and the dorsal-ventral axis in the limb. Genes & Development 2003, 17(16):1963-1968.
94. Stolt C.C., Rehberg S., Ader M., Lommes P., Riethmacher D., Schachner M., et al. Terminal differentiation of mylein-forming oligodendroyctes depends on the transcription factor Sox 10. Genes and Development 2002, 16:165-170.
95. Tang X.-M., Beesley J.S., Grinspan J.B., Seth P., Kamholz J., Cambi F. Cell cycle arrest induced by ectopic expression of p27 is not sufficient to promote oligodendorcyte differentiation. Journal of Cellular Biochemistry 1999, 76:270-279.
96. Thorburne S., Juurlink B.H. Low glutathione and high iron govern the suceptibility of oligodendroglial precursors to oxidative stress. Journal of Neurochemistry 1996, 67:1014-1022.
97. Tsai H.H., Miller R.H. Glial cell migration directed by axon guidance cues. Trends in Neurosciences 2002, 25(4):173-175. (discussion 175-176).
98. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatric Research 2001, 50(5):553-562.
99. Wada T., Kagawa T., Ivanova A., Zalc B., Shirasaki R., Murakami F., et al. Dorsal spinal cord inhibits oligodendrocyte development. Developmental Biology 2000, 227(1):42-55.
100. Wang S., Sdrulla A., Johnson J.E., Yokota Y., Barres B.A. A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development. Neuron 2001, 29(3):603-614.
101. Weng Q., Chen Y., Wang H., Xu X., Yang B., He Q., et al. Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system. Neuron 2012, 73(4):713-728.
102. Wine-Lee L., Ahn K.J., Richardson R.D., Mishina Y., Lyons K.M., Crenshaw E.B. Signaling through BMP type 1 receptors is required for development of interneuron cell types in the dorsal spinal cord. Development 2004, 131(21):5393-5403.
103. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature 1994, 370(6488):341-347.
104. Wu M., Hernandez M., Shen S., Sabo J.K., Kelkar D., Wang J., et al. Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation. Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2012, 32(19):6651-6664.
105. Xiao Q., Du Y., Wu W., Yip H.K. Bone morphogenetic proteins mediate cellular response, and together with Noggin, regulate astrocyte differentiation after spinal cord injury. Experimental Neurology 2010, 221(2):353-366.
106. Ye F., Chen Y., Hoang T., Montgomery R.L., Zhao X.H., Bu H., et al. HDAC1 asnd HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction. Nature Neuroscience 2009, 12:829-838.
107. Zhang H., Miller R.H. Density-dependent feedback inhibition of oligodendrocyte precursor expansion. The Journal of Neuroscience 1996, 16(21):6886-6895.
108. Zhao C., Fancy S.P.J., Magy L., Urwin J.E., Franklin R.J.M. Stem cells, progenitors and myelin repair. Journal of Anatomy 2005, 207:251-258.
109. Zhou Q., Choi G., Anderson D.J. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 2001, 31(5):791-807.
110. Zhou Q., Wang S., Anderson D.J. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000, 25:331-343.